Brian Silver to Fibrinolytic Agents
This is a "connection" page, showing publications Brian Silver has written about Fibrinolytic Agents.
Connection Strength
2.283
-
Silver B, Behrouz R. Endovascular therapy for ischemic stroke. N Engl J Med. 2015 06 11; 372(24):2364-5.
Score: 0.431
-
Behrouz R, Mutgi SA, Silver B. Letter by Behrouz et Al regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion". Stroke. 2015 Jun; 46(6):e149.
Score: 0.427
-
Assaad B, Sesi VK, Figari R, Schultz L, Thummala N, Rehman M, Chandok A, Silverman A, Silver B. Antithrombotic management of stroke patients before colonoscopy. J Stroke Cerebrovasc Dis. 2013 Aug; 22(6):733-6.
Score: 0.340
-
Agarwal S, Scher E, Lord A, Frontera J, Ishida K, Torres J, Rostanski S, Mistry E, Mac Grory B, Cutting S, Burton T, Silver B, Liberman AL, Lerario MP, Furie K, Grotta J, Khatri P, Saver J, Yaghi S. Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo. Stroke. 2020 04; 51(4):1226-1230.
Score: 0.149
-
Azeem MU, Nagy M, Miller MM, Ghasemi M, Mikati A, Silver B, Moonis M, Henninger N. Prevalence of a Multiple Territory Stroke Pattern After Intravenous Thrombolysis. J Stroke Cerebrovasc Dis. 2020 May; 29(5):104700.
Score: 0.149
-
Behrouz R, Masju?n-Vallejo J, Vera R, Willey JZ, Zedet M, Moulin S, Cordonnier C, Klijn CJM, Kanselaar K, Dirks M, Silver B, Khan M, Azarpazhooh MR, Godoy DA, Roffe C, Paley L, Bray BD, Smith CJ, Di Napoli M. Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous Thrombolytics. J Stroke Cerebrovasc Dis. 2018 Jan; 27(1):246-256.
Score: 0.126
-
Saber H, Silver B, Santillan A, Azarpazhooh MR, Misra V, Behrouz R. Role of emergent chest radiography in evaluation of hyperacute stroke. Neurology. 2016 Aug 23; 87(8):782-5.
Score: 0.116
-
Silver B, Wulf Silver R. Stroke: diagnosis and management of acute ischemic stroke. FP Essent. 2014 May; 420:16-22.
Score: 0.100
-
Phan TG, Demchuk A, Srikanth V, Silver B, Patel SC, Barber PA, Levine SR, Hill MD. Proof of concept study: relating infarct location to stroke disability in the NINDS rt-PA trial. Cerebrovasc Dis. 2013; 35(6):560-5.
Score: 0.094
-
Silver B, Miller D, Jankowski M, Murshed N, Garcia P, Penstone P, Straub M, Logan SP, Sinha A, Morris DC, Katramados A, Russman AN, Mitsias PD, Schultz LR. Urine toxicology screening in an urban stroke and TIA population. Neurology. 2013 Apr 30; 80(18):1702-9.
Score: 0.093
-
Demchuk AM, Khan F, Hill MD, Barber PA, Silver B, Patel S, Levine SR. Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study. Cerebrovasc Dis. 2008; 26(2):120-5.
Score: 0.066
-
Saposnik G, Young B, Silver B, Di Legge S, Webster F, Beletsky V, Jain V, Nilanont Y, Hachinski V. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. JAMA. 2004 Oct 20; 292(15):1839-44.
Score: 0.052
-
Morris DC, Silver B, Mitsias P, Lewandowski C, Patel S, Daley S, Zhang ZG, Lu M. Treatment of acute stroke with recombinant tissue plasminogen activator and abciximab. Acad Emerg Med. 2003 Dec; 10(12):1396-9.
Score: 0.048
-
Foell RB, Silver B, Merino JG, Wong EH, Demaerschalk BM, Poncha F, Tamayo A, Hachinski V. Effects of thrombolysis for acute stroke in patients with pre-existing disability. CMAJ. 2003 Aug 05; 169(3):193-7.
Score: 0.047
-
Merino JG, Silver B, Wong E, Foell B, Demaerschalk B, Tamayo A, Poncha F, Hachinski V. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke. 2002 Jan; 33(1):141-6.
Score: 0.042